T-Cell Neoplasms – Decode the Mysteries of Sample Analysis and Optimized Data Flow
In this three-part webinar series, we invite you to explore the benefits of a standardized workflow in leukemia and lymphoma analysis. Join this showcase of Beckman Coulter’s new DxFLEX flow cytometer, designed to advance standardization and simplification in clinical laboratories.
The second webinar delves into diseases originating from the T-cell lineage. Tia LaBarge, an expert in T-cell neoplasms, provides detailed insights into their analysis strategies. Antoine Pacheco, Platform Manager for Clinical Instrumentation at Beckman Coulter, will broadcast from the laboratory, demonstrating the seamless integration of the DxFLEX flow cytometer with the LIS (Laboratory Information System).
Discover more about our three-part series and register for the other webinars here:
Key learning objectives
- Gain insights into the diagnosis of B-cell, T-cell and myeloid-cell-derived neoplasms
- Learn how to standardize and streamline leukemia and lymphoma analysis
- Discover how APD-detectors in a flow cytometer can help you to add more colors to your panels without adding more concerns
Who should attend?
- Clinical laboratory managers
- Clinical laboratory scientists
- Medical/Laboratory technicians
- Hematopathologists
- Laboratory QA managers
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes
Speakers
Tia LaBarge is the Manager of Laboratory Services and Technical Supervisor at the University of Rochester Medical Center. With 20 years of experience in leukemia and lymphoma testing, HLA/tissue typing, and microbiology, she is dedicated to advancing patient care. Her passion for patient well-being drives her commitment to excellence and innovation in laboratory services.
Antoine Pacheco, an electronic engineer by training, began his career at Beckman Coulter in 1987 as an application specialist for chemistry instruments. His expertise and dedication led him to a role in international support for flow cytometry sorters in 1992. He now serves in a global position for clinical flow cytometry, demonstrating his commitment to advancing the field and contributing to Beckman Coulter's success.